A controlled trial of diazepam withdrawal in chronically anxious outpatients

Authors:

Abstract
Twenty‐four middle‐aged male chronically anxious outpatients who were taking diazepam at a mean dose of 17 mg/day for a mean duration of 5 years were assigned to maintenance (M), gradual withdrawal (GW) or abrupt withdrawal (AW) and followed weekly. No differences were seen in two self‐report anxiety measures or in withdrawal symptoms between groups. Hamilton Anxiety Rating Scale scores were slightly elevated (F = 2.34, P < 0.05) in the AW patients at a mean duration of 4 weeks off diazepam. Thus, withdrawal from chronic diazepam (10–30 mg/day) use produced no prominent withdrawal syndrome, but the suggestion of graduai anxiety recurrence indicates the need for longer‐term follow‐up studies to adequately assess maintenance efficacy.

This publication has 11 references indexed in Scilit: